ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

175 hedge funds and large institutions have $899M invested in Acorda Therapeutics in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
175
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.01M
Puts
$40.8M
Net Calls
Net Calls Change

Top Buyers

1 +$13.5M
2 +$11.8M
3 +$6.17M
4
SM
Sabby Management
Florida
+$4.96M
5
Millennium Management
Millennium Management
New York
+$4.58M

Top Sellers

1 -$13M
2 -$10.3M
3 -$8.01M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$7.43M
5
Goldman Sachs
Goldman Sachs
New York
-$7.15M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.12M
77
$1.11M
78
$1.1M
79
$1.09M
80
$1.05M
81
$1.03M
82
$1.02M
83
$971K
84
$958K
85
$915K
86
$884K
87
$880K
88
$877K
89
$850K
90
$842K
91
$833K
92
$818K
93
$767K
94
$762K
95
$737K
96
$729K
97
$722K
98
$717K
99
$696K
100
$691K